BACKGROUND: Our recent data indicate that 21% of critically ill, adult, multiple-trauma patients receiving specialized nutrition support experience hypocalcemia. However, evidence-based methods for the treatment of moderate to severe acute hypocalcemia (ionized calcium concentration [iCa] <1 mmol/L) are lacking. METHODS: The efficacy of an infusion of 4 g of calcium gluconate was evaluated in 20 critically ill, adult, multiple-trauma patients with moderate to severe hypocalcemia (iCa <1 mmol/L). The calcium gluconate was infused at a rate of 1 g/h in a small volume admixture. A serum iCa determination was obtained on the following day. RESULTS: Calcium gluconate infusion significantly increased serum iCa from 0.90 +/- 0.08 mmol/L to 1.16 +/- 0.11 mmol/L (p < .001) on the following day. This dosage regimen was successful for achieving a serum iCa >1 mmol/L for 19 of 20 (95%) hypocalcemic patients and achieved a concentration >1.12 mmol/L in 14 (70%) of the patients. Two patients developed mild hypercalcemia (iCa of 1.34 mmol/L and 1.38 mmol/L) postinfusion. CONCLUSIONS: A short-term infusion of 4 g of intravenous (IV) calcium gluconate for the treatment of moderate to severe hypocalcemia appears to be a promising regimen for critically ill, adult, multiple-trauma patients.
BACKGROUND: Our recent data indicate that 21% of critically ill, adult, multiple-traumapatients receiving specialized nutrition support experience hypocalcemia. However, evidence-based methods for the treatment of moderate to severe acute hypocalcemia (ionizedcalcium concentration [iCa] <1 mmol/L) are lacking. METHODS: The efficacy of an infusion of 4 g of calcium gluconate was evaluated in 20 critically ill, adult, multiple-traumapatients with moderate to severe hypocalcemia (iCa <1 mmol/L). The calcium gluconate was infused at a rate of 1 g/h in a small volume admixture. A serum iCa determination was obtained on the following day. RESULTS:Calcium gluconate infusion significantly increased serum iCa from 0.90 +/- 0.08 mmol/L to 1.16 +/- 0.11 mmol/L (p < .001) on the following day. This dosage regimen was successful for achieving a serum iCa >1 mmol/L for 19 of 20 (95%) hypocalcemicpatients and achieved a concentration >1.12 mmol/L in 14 (70%) of the patients. Two patients developed mild hypercalcemia (iCa of 1.34 mmol/L and 1.38 mmol/L) postinfusion. CONCLUSIONS: A short-term infusion of 4 g of intravenous (IV) calcium gluconate for the treatment of moderate to severe hypocalcemia appears to be a promising regimen for critically ill, adult, multiple-traumapatients.
Authors: Andy B Chen; Kazumasa Minami; João F Raposo; Nariaki Matsuura; Masahiko Koizumi; Hiroki Yokota; Hugo G Ferreira Journal: Endocrine Date: 2016-08-08 Impact factor: 3.633
Authors: Vinas-Rios Juan Manuel; Sanchez-Aguilar Martin; Sanchez-Rodriguez Jose Juan; Muruato-Araiza Luis Fernando; Meyer Frerk; Kretschmer Thomas; Heinen Christian Journal: Asian J Neurosurg Date: 2015 Jul-Sep
Authors: Roland N Dickerson; Christin N Crawford; Melissa K Tsiu; Cara E Bujanowski; Edward T Van Matre; Joseph M Swanson; Dina M Filiberto; Gayle Minard Journal: Nutrients Date: 2021-05-15 Impact factor: 5.717
Authors: Mayank Vasudeva; Joseph K Mathew; Christopher Groombridge; Jin W Tee; Cecil S Johnny; Amit Maini; Mark C Fitzgerald Journal: J Trauma Acute Care Surg Date: 2021-02-01 Impact factor: 3.697